M86.39
Chronic multifocal osteomyelitis, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic multifocal osteomyelitis (CMO) with multiple sites, classified under ICD-10 code M86.39, is a rare inflammatory condition affecting various bones in the body. Unlike acute infections, CMO develops slowly and persists over time, leading to bone damage and discomfort. It primarily impacts children and young adults but can occur at any age. Recognizing the signs and understanding the causes and treatments can help manage this condition effectively.
Causes & Symptoms
Clinical Causes: Unknown exact cause, but believed to involve abnormal immune system activity Possible autoimmune responses where the body's immune system mistakenly attacks bone tissue Persistent bacterial infections that become chronic Genetic predispositions influencing immune regulation History of trauma or injury to bones
Key Symptoms: Bone pain, often deep and persistent Swelling and tenderness over affected areas Limited range of motion in nearby joints Fever and general malaise in some cases Fatigue and weight loss in prolonged cases Localized redness over affected bones
Diagnostic & Treatment
Diagnosis Path: Diagnosing chronic multifocal osteomyelitis involves a combination of clinical evaluation and diagnostic tests. Healthcare providers typically perform: - **Medical history and physical examination** to assess symptoms and possible affected sites - **Blood tests** such as complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) to detect inflammation - **Imaging studies** including X-rays, MRI, or bone scans to identify areas of bone inflammation and damage - **Biopsy** of affected bone tissue to rule out bacterial infections and confirm inflammation Since CMO can mimic other bone diseases, thorough testing is essential for accurate diagnosis.
Treatment Protocols: Managing chronic multifocal osteomyelitis focuses on reducing inflammation, relieving pain, and preventing further bone damage. Treatment strategies may include: - **Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):** To reduce inflammation and manage pain - **Corticosteroids:** In cases of significant inflammation that do not respond to NSAIDs - **Immunosuppressive medications:** Such as methotrexate or biologic agents for immune system regulation - **Antibiotics:** Only if a bacterial infection is identified or suspected, but often not effective alone - **Physical therapy:** To maintain joint mobility and muscle strength - **Surgical intervention:** Rarely required, but possible in cases of severe bone destruction or abscess formation Long-term management includes regular monitoring and supportive care to prevent complications and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is M86.39 a billable ICD-10 code?
Yes, M86.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M86.39?
Clinical documentation must specify the nature of Chronic multifocal osteomyelitis, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference